Skip to main content
. 2022 Apr 29;10(5):703. doi: 10.3390/vaccines10050703

Figure 3.

Figure 3

Data show the progression of the neutralizing antibody titer (NT-Ab) in the naïve HCW (left) and exposed-HCW cohorts (right). In both groups, there was a reduction in the NT-Ab at 6 months post-2nd dose, but the titer was recovered at 1 month after the 3rd dose.